Andreessen Horowitz (a16z)THE DEAL, AT A GLANCE
From the announcementGeneral Medicine
Who is involvedBacked by Andreessen Horowitz (a16z), Matrix, VXI Capital, Eli LillyFrom the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗What happenedGeneral Medicine raised Series B, announced 2026-11-03From the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗Why it mattersGeneral Medicine's investment case depends on whether it can convert its Series B funding and investor relationships into a scalable healthcare business.From the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗Click a part to explore its evidence. Unsupported imagery is withheld rather than guessed.Original record source ↗
General Medicine · Financing Record
Explore source-linked visual explanations for General Medicine. Unsupported claims are withheld while source review continues.
Record 15556 · Recorded date: 2026-11-03
Explore company records →